400314006: Product containing paracetamol and phenyltoloxamine citrate and salicylamide (medicinal product)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1768234015 Acetaminophen + phenyltoloxamine citrate + salicylamide (product) en Fully specified name Inactive Only initial character case insensitive (core metadata concept) SNOMED CT core
1773515018 Paracetamol + phenyltoloxamine citrate + salicylamide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1774801019 Acetaminophen + phenyltoloxamine citrate + salicylamide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3490647016 Product containing paracetamol and phenyltoloxamine citrate and salicylamide (medicinal product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3494842017 Product containing acetaminophen and phenyltoloxamine citrate and salicylamide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3494843010 Product containing paracetamol and phenyltoloxamine citrate and salicylamide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3829951000005119 acetaminophen + phenyltoloxamincitrat + salicylamid da Synonym (core metadata concept) Inactive Entire term case insensitive (core metadata concept) Danish module (core metadata concept)
4743901000005119 paracetamol + phenyltoloxamincitrat + salicylamid da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
paracetamol + phenyltoloxamincitrat + salicylamid	Is a	paracetamol + phenyltoloxamincitrat	false	Inferred relationship	Some
paracetamol + phenyltoloxamincitrat + salicylamid	Is a	Product containing salicylamide (medicinal product)	false	Inferred relationship	Some
paracetamol + phenyltoloxamincitrat + salicylamid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Salicylamide	false	Inferred relationship	Some
paracetamol + phenyltoloxamincitrat + salicylamid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Ethanolamine	false	Inferred relationship	Some
paracetamol + phenyltoloxamincitrat + salicylamid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Paracetamol	false	Inferred relationship	Some
paracetamol + phenyltoloxamincitrat + salicylamid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Phenyltoloxamine (substance)	false	Inferred relationship	Some
paracetamol + phenyltoloxamincitrat + salicylamid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Phenyltoloxamine citrate	false	Inferred relationship	Some
paracetamol + phenyltoloxamincitrat + salicylamid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Cardiovascular agent (substance)	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug)	Is a	False	paracetamol + phenyltoloxamincitrat + salicylamid	Inferred relationship	Some
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	Is a	False	paracetamol + phenyltoloxamincitrat + salicylamid	Inferred relationship	Some

Reference Sets

Concept inactivation indicator reference set